Imatinib to Increase RUNX1 Activity in Participants With Germline RUNX1 Deficiency
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Children's Hospital of Philadelphia
Dana-Farber Cancer Institute
Mayo Clinic
Stanford University